SUZHOU, China, Nov. 16, 2018 /PRNewswire/ -- WuXi AppTec announces today that its Laboratory Testing Division's new MedicalDevice Testing Center opens today in Suzhou, China. This marks the full implementation of WuXi AppTec's medical device testing capabilities in the Chinese market, which works with its existing United
"WuXi AppTec's Laboratory Testing Division provides a world-class, globally integrated testing solution for drug and medical device development and manufacturing. We enable scientists to transform ideas into healthcare products, accelerate the development and commercialization from bench to bedside," said Dr. Jason Liu, Senior Vice President of WuXi AppTec and Chief Operating Officer of WuXi AppTec's Laboratory Testing Division. By providing integrated medical device testing and regulatory services from research and development to commercialization, WuXi AppTec's Laboratory Testing Division enables medical device companies to efficiently control product quality in its product life cycle from R&D to commercial sales.
The new medical device testing center operates in 15,000 square meters facility in Suzhou. Through the transfer of the capabilities, operation and quality management system of WuXi AppTec's United States-based Medical Device Testing Center, the new center will provide comprehensive medical device testing services that are in compliance with international quality standards. Its testing services will include biomaterials analysis, toxicology, biocompatibility, risk assessment, product aseptic design microbiology, physical testing of packaging and shelf life, product batch release testing and more. The new center will enable medical device companies worldwide to bring the leading medical and health products to patients in China and around the world.
About WuXi AppTec
WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities such as small molecule drug R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, drug R&D and medical device testing, WuXi platform is enabling more than 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi's dream that "every drug can be made and every disease can be treated."
View original content:http://www.prnewswire.com/news-releases/wuxi-apptec-opens-its-new-medical-device-testing-center-in-suzhou-300751966.html
SOURCE WuXi AppTec
Subscribe to our Free Newsletters!